Coronavirus to disrupt EU pharma drug launches, analysts warnBig European launches of drugs for cancer, HIV, and sickle cell disease could be affected by coronavirus, according Share XCoronavirus to disrupt EU pharma drug launches, analysts warnhttps://pharmaphorum.com/news/coronavirus-to-disrupt-eu-pharma-drug-launches-analysts-warn/
Pharma staff told to work at home as Biogen deals with coronavirus outbreakThe coronavirus has begun to affect day-to-day operations at pharma companies, with Biogen dealing with an outbreak linked Share XPharma staff told to work at home as Biogen deals with coronavirus outbreakhttps://pharmaphorum.com/news/biogen-deals-with-staff-coronavirus-outbreak/
NICE rejects NHS funding Sanofi/Regeneron’s Dupixent in asthmaNICE has said “no” to regular NHS funding for Sanofi and Regeneron’s Dupixent (dupilumab) for severe asthma in Share XNICE rejects NHS funding Sanofi/Regeneron’s Dupixent in asthmahttps://pharmaphorum.com/news/nice-rejects-nhs-funding-sanofi-regenerons-dupixent-in-asthma/
Takeda and Arcturus join hunt for coronavirus therapiesThe Japanese drugs giant Takeda and the US biotech Arcturus Therapeutics have joined the hunt for therapies for Share XTakeda and Arcturus join hunt for coronavirus therapieshttps://pharmaphorum.com/news/takeda-and-arcturus-join-hunt-for-coronavirus-therapies/
Sanofi gets first OK for isatuximab for myeloma, challenging J&J’s DarzalexSanofi has claimed FDA approval for its anti-CD38 drug isatuximab as a third-line treatment for multiple myeloma, becoming Share XSanofi gets first OK for isatuximab for myeloma, challenging J&J’s Darzalexhttps://pharmaphorum.com/news/sanofi-gets-first-ok-for-isatuximab-for-myeloma-challenging-jjs-darzalex/
Chinese biotech censured for misleading coronavirus drug claimsChina’s BrightGene Bio-Medical Technology has been censured by the Shanghai Stock Exchange for wrongly claiming it is able Share XChinese biotech censured for misleading coronavirus drug claimshttps://pharmaphorum.com/news/chinese-biotech-censured-for-misleading-coronavirus-drug-claims/
Sanofi’s Bozidar Jovicevic on how the company is approaching digital therapeuticsPaul Tunnah caught up with Sanofi’s vice president, global head of digital therapeutics at JP Morgan to talk Share XSanofi’s Bozidar Jovicevic on how the company is approaching digital therapeuticshttps://pharmaphorum.com/video/sanofis-bozidar-jovicevic-on-how-the-company-is-approaching-digital-therapeutics/
Sanofi to combat shortages with European medicines ingredient firmSanofi is to create a European company focused on production and marketing of active pharmaceutical ingredients (API) – Share XSanofi to combat shortages with European medicines ingredient firmhttps://pharmaphorum.com/news/sanofi-to-combat-shortages-with-european-medicines-ingredient-firm/
Sanofi Pasteur to develop COVID-19 vaccine with US governmentSanofi Pasteur, the global vaccines business unit of the French drug maker Sanofi, has joined forces with a Share XSanofi Pasteur to develop COVID-19 vaccine with US governmenthttps://pharmaphorum.com/news/sanofi-pasteur-to-develop-covid-19-vaccine-with-us-government/
